Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Truist Securities Initiates Coverage On Medpace Hldgs with Hold Rating, Announces Price Target of $415

Author: Benzinga Newsdesk | August 01, 2024 05:29am
Truist Securities analyst Jailendra Singh initiates coverage on Medpace Hldgs (NASDAQ:MEDP) with a Hold rating and announces Price Target of $415.

Posted In: MEDP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist